All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

Vinod Thourani, MD
Disclosure(s): Abbott Vascular: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Artivion: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); AtriCure: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Boston Scientific: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); dasi simulations: Advisory Board (Ongoing); Edwards Life Science: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Jenavalve: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Medtronic: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)

Patrick Myers, MD

Presentations

1. The 5 Year Results of PARTNER 3 Favor More SAVR in Low-Risk Patients
   Michael Mack, MD
   Disclosure(s): Carmat: Corporate Board Member (Ongoing); Edwards Lifesciences: Trial Co-PI (Ongoing); Medtronic: Study Chair (Ongoing)
    
2. The 5 Year Results of PARTNER 3 Favor More TAVR in Low-Risk Patients
   Gry Dahle, MD, PhD
    
3. Transcatheter Tricuspid Valve Replacement: Obtaining the Necessary Skills for Success
   James Stewart, MD, FACC
    
4. Transcatheter Tricuspid Valve Repair: Is This the New Gold Standard Instead of Surgical Repair?
   Gorav Ailawadi, MD, MBA
   Disclosure(s): edwards, Abbott, Anteris, Nyra, Medtronic, Arthrex, J&J, Philips: Advisory Board (Ongoing), Consultant (Ongoing)
    
5. Hybrid and Surgical AF Ablation: What the Surgeons Need to Know
   Patrick Myers, MD
    
6. Randomized Trials by Surgeons for Surgeons: CTSN
   Annetine Gelijns, PhD